FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987851044> ?p ?o ?g. }

• W2987851044 abstract "Multiple sclerosis (MS) is a chronic autoimmune and degenerative disease of the central nervous system, and conventional treatments have limited efficacy or side effects. Ghrelin, a 28-amino acid octanoylated peptide, has been reported to have neuroprotective effects, including anti-oxidation, anti-inflammation, and anti-apoptosis. Pyroptosis, also called inflammatory cell death, is triggered by overly active inflammasomes and accompanied by the production of numerous cytokines. As immune dysfunction is primarily involved in the pathogenesis of MS, this study aimed to explore the therapeutic effects and precise functional mechanisms of ghrelin against the nod-like receptor protein 3 (NLRP3) inflammasome and pyroptosis in experimental autoimmune encephalomyelitis (EAE). Sprague Dawley rats were immunized with guinea pig spinal cord homogenates and pertussis toxin to develop an EAE model. All rats were randomly divided into four groups: normal control group, EAE group, EAE + ghrelin group, and ghrelin control group. EAE rats showed abnormal behavioral scores and body weight changes. Histologic analysis displayed severe inflammatory infiltration and demyelination in the brain and spinal cord of EAE rats. Ghrelin treatments potently restored these abnormal changes. In addition, the ghrelin-treated EAE group showed significantly downregulated expression of inflammatory cytokines. The expression of proteins involved in the NLRP3 signaling pathway and pyroptosis was decreased as well. We also found that the anti-inflammatory effect of ghrelin was associated with inhibition of nuclear factor (NF)-κB activation. Compared with rats in the healthy control group, rats in the ghrelin control group did not show statistically significant changes in histologic examinations, pro-inflammatory cytokines production, or molecules involved in the NLRP3 signaling pathway, which indicated that ghrelin induced no side effects in the animals of our study. Our findings provide more insight into the use of ghrelin as a novel candidate for MS." @default.
• W2987851044 created "2019-11-22" @default.
• W2987851044 creator A5037027565 @default.
• W2987851044 creator A5048038908 @default.
• W2987851044 creator A5048279362 @default.
• W2987851044 creator A5055517335 @default.
• W2987851044 creator A5060849386 @default.
• W2987851044 date "2019-11-06" @default.
• W2987851044 modified "2023-09-28" @default.
• W2987851044 title "Ghrelin Attenuates Neuroinflammation and Demyelination in Experimental Autoimmune Encephalomyelitis Involving NLRP3 Inflammasome Signaling Pathway and Pyroptosis" @default.
• W2987851044 cites W1842603578 @default.
• W2987851044 cites W1864325817 @default.
• W2987851044 cites W1991742828 @default.
• W2987851044 cites W1996072332 @default.
• W2987851044 cites W2034678408 @default.
• W2987851044 cites W2052644415 @default.
• W2987851044 cites W2065747719 @default.
• W2987851044 cites W2086406618 @default.
• W2987851044 cites W2090644845 @default.
• W2987851044 cites W2096317294 @default.
• W2987851044 cites W2101615174 @default.
• W2987851044 cites W2117070932 @default.
• W2987851044 cites W2133436347 @default.
• W2987851044 cites W2154011346 @default.
• W2987851044 cites W2157118250 @default.
• W2987851044 cites W2159447484 @default.
• W2987851044 cites W2163865122 @default.
• W2987851044 cites W2168072744 @default.
• W2987851044 cites W2175794645 @default.
• W2987851044 cites W2191253512 @default.
• W2987851044 cites W2266983444 @default.
• W2987851044 cites W2302151110 @default.
• W2987851044 cites W2396044725 @default.
• W2987851044 cites W2517997111 @default.
• W2987851044 cites W2544079919 @default.
• W2987851044 cites W2554239825 @default.
• W2987851044 cites W2560541542 @default.
• W2987851044 cites W2561306779 @default.
• W2987851044 cites W2562773331 @default.
• W2987851044 cites W2582620106 @default.
• W2987851044 cites W2591960163 @default.
• W2987851044 cites W2605685784 @default.
• W2987851044 cites W2736346397 @default.
• W2987851044 cites W2744998504 @default.
• W2987851044 cites W2745119837 @default.
• W2987851044 cites W2808342347 @default.
• W2987851044 cites W2884031535 @default.
• W2987851044 cites W2894219590 @default.
• W2987851044 cites W2897081989 @default.
• W2987851044 cites W2899386772 @default.
• W2987851044 cites W2904668262 @default.
• W2987851044 cites W2907424910 @default.
• W2987851044 cites W2950108352 @default.
• W2987851044 cites W2958001455 @default.
• W2987851044 cites W2980321266 @default.
• W2987851044 doi "https://doi.org/10.3389/fphar.2019.01320" @default.
• W2987851044 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6851267" @default.
• W2987851044 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31780940" @default.
• W2987851044 hasPublicationYear "2019" @default.
• W2987851044 type Work @default.
• W2987851044 sameAs 2987851044 @default.
• W2987851044 citedByCount "38" @default.
• W2987851044 countsByYear W29878510442020 @default.
• W2987851044 countsByYear W29878510442021 @default.
• W2987851044 countsByYear W29878510442022 @default.
• W2987851044 countsByYear W29878510442023 @default.
• W2987851044 crossrefType "journal-article" @default.
• W2987851044 hasAuthorship W2987851044A5037027565 @default.
• W2987851044 hasAuthorship W2987851044A5048038908 @default.
• W2987851044 hasAuthorship W2987851044A5048279362 @default.
• W2987851044 hasAuthorship W2987851044A5055517335 @default.
• W2987851044 hasAuthorship W2987851044A5060849386 @default.
• W2987851044 hasBestOaLocation W29878510441 @default.
• W2987851044 hasConcept C126322002 @default.
• W2987851044 hasConcept C134018914 @default.
• W2987851044 hasConcept C164027704 @default.
• W2987851044 hasConcept C170493617 @default.
• W2987851044 hasConcept C17172800 @default.
• W2987851044 hasConcept C203014093 @default.
• W2987851044 hasConcept C25498285 @default.
• W2987851044 hasConcept C2776914184 @default.
• W2987851044 hasConcept C2777209026 @default.
• W2987851044 hasConcept C2778486448 @default.
• W2987851044 hasConcept C2779357093 @default.
• W2987851044 hasConcept C2780942790 @default.
• W2987851044 hasConcept C71924100 @default.
• W2987851044 hasConcept C87753298 @default.
• W2987851044 hasConcept C98274493 @default.
• W2987851044 hasConceptScore W2987851044C126322002 @default.
• W2987851044 hasConceptScore W2987851044C134018914 @default.
• W2987851044 hasConceptScore W2987851044C164027704 @default.
• W2987851044 hasConceptScore W2987851044C170493617 @default.
• W2987851044 hasConceptScore W2987851044C17172800 @default.
• W2987851044 hasConceptScore W2987851044C203014093 @default.
• W2987851044 hasConceptScore W2987851044C25498285 @default.
• W2987851044 hasConceptScore W2987851044C2776914184 @default.
• W2987851044 hasConceptScore W2987851044C2777209026 @default.
• W2987851044 hasConceptScore W2987851044C2778486448 @default.
• W2987851044 hasConceptScore W2987851044C2779357093 @default.
• W2987851044 hasConceptScore W2987851044C2780942790 @default.

• next